Electrochemotherapy for breast cancer-results from the INSPECT database.
Authors
Matthiessen, LKeshtgar, M
Curatolo, P
Kunte, C
Grischke, E
Odili, J
Muir, T
Mowatt, David J
Clover, J
Liew, S
Dahlstroem, K
Newby, J
Letulé, V
Stauss, E
Humphreys, A
Banerjee, S
Klein, A
Rotunno, R
de Terlizzi, F
Gehl, J
Affiliation
Department of Oncology, Copenhagen University Hospital Herlev and Gentofte, Herlev, DenmarkIssue Date
2018-03-14
Metadata
Show full item recordAbstract
Cutaneous recurrence from breast cancer can pose a clinical challenge. It might be the only disease site, or could be part of disseminated disease, and often profoundly affects quality of life. Electrochemotherapy is a palliative treatment using electric pulses to locally permeabilize tumor cells and thereby significantly increase bleomycin cytotoxicity. Collaborating with the International Network for Sharing Practice on ElectroChemoTherapy (INSPECT), we consecutively and prospectively accrued data on patients treated with electrochemotherapy for cutaneous metastases from breast cancer.Citation
Electrochemotherapy for breast cancer-results from the INSPECT database. 2018, Clin Breast CancerJournal
Clinical Breast CancerDOI
10.1016/j.clbc.2018.03.007PubMed ID
29673795Type
ArticleLanguage
enISSN
1938-0666ae974a485f413a2113503eed53cd6c53
10.1016/j.clbc.2018.03.007